The Future of Pediatric Oncology: ATR Inhibition and the Evolution of Hepatoblastoma Management
Episode Summary
ATR inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm.